Skip to main content

Home/ Nutrition/ Group items tagged EPA statin medscape

Rss Feed Group items tagged

Matti Narkia

JELIS - Japan Eicosapentaenoic acid (EPA) Lipid Intervention Study - Medscape - 0 views

  •  
    The first large-scale, prospective, randomized trial of combined treatment with a statin and an omega-3 fatty acid originally derived from fish, eicosapentaenoic acid (EPA), has shown that the addition of EPA to statin therapy provides additional benefit in preventing major coronary events, apparently through lipid-independent mechanisms.[1] The Japan eicosapentaenoic acid (EPA) Lipid Intervention Study (JELIS) tested the effects of long-term use of EPA 1800 mg/day in addition to a statin in Japanese patients with hypercholesterolemia. The results add support to previous evidence of the beneficial effect of omega-3 fatty acids in patients with known coronary heart disease, and show that that effect can extend the benefit of statins, the JELIS investigators believe
1 - 1 of 1
Showing 20 items per page